(UTC+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna
Andree Blaukat
CEO, Tessellate BIO
Anne Vroon
Vice President, Business Development, Genmab
Frank Grosveld
Professor, Erasmus MC
Jolanda Crombach
General Manager, Moderna
Elise de Reus
Co-Founder, Cradle
Wiro Niessen
Dean, Board Member & Professor, UMCG
Michal Preminger
Head of Innovation, Johnson & Johnson
Dirk van Asseldonk
CEO, LentiCure
Marianne Verhaar
Professor of Experimental Nephrology, UMC Utrecht
Stanleyson Hato
Team Lead Life Sciences & Health, Invest-NL
Erik van den Berg
CEO, MemoTherapeutics AG
Carmen van Vilsteren
Chair, Health~Holland
Eliane Schutte
CEO, Xeltis
Hans Schikan
Top Team Member Life Sciences & Health, Health~Holland
Kasper Roet
CEO & Founder, QurAlis
Maroeska Rovers
Scientific Director TechMed Centre, University of Twente
Sascha Oliver Bucher
Co-Founding Partner, Forty51 Ventures
Ted Fjällman
CEO, Flerie
Jérôme Van Biervliet
Managing Director, VIB
Stefan Volk Jovinge
Adjunct Professor, Lund University
Willem Mulder
Professor of Precision Medicine, TU Eindhoven
Anant Murthy
Co-Founder and Board Member, Avanzanite Bioscience
Eline van Beest
CEO, Hybridize Therapeutics & Operational Partner, Thuja Capital
Yael Weiss
CEO, Mahzi Therapeutics
Ed Kaye
CEO & Director, Stoke Therapeutics
Noortje Bax
Chair, 4TU.Health Centre
Paul Korte
Board Member, FAST
Brian Woolhouse
Managing Director, MSD Netherlands
Eleanor Price
Associate, Thuja Capital
Sangbreeta Moitra
TEDX-awarded Keynote Speaker & Executive Leadership Coach
Pernilla Isberg
Director, AstraZeneca BioVentureHub
Inge Jedema
Co-lead Cell and Gene Therapy, Oncode Accelerator
Jessie van Buggenum
Manager Thematic Cluster ATMPs, Biotech Booster
Wim van Hartingsveldt
Business Development Manager, TNO
Willem van den Brink
Senior Scientist, TNO
Kevin Witlox
Scientist Innovator, TNO
Jayeeta Sengupta
Program Manager, TNO
Natallia Uzunbajakava
Senior Scientist, TNO
Michiel Oderwald
Senior Business Developer, TNO
Kinga Matuła
CEO, QurieGen
Eva-Karin Gidlund
Chief Business Officer, NorthX Biologics
Koenraad Wiedhaup
CEO, Leyden Labs
Barend Bouma
Dutch and European Patent Attorney AP, NLO
Mark Wijsman
Chair
Robert-Jan van der Vorm
Director Corporate Finance, Van Lanschot Kempen
Jessica Vermeulen
Vice President Clinical R&D, Johnson & Johnson
Leoni Delsink
Portfolio Manager, VGZ